Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

  • 1 September 2012 to 31 March 2014
  • Awards: Pump-priming Awards

The relevance of vitamin D for prevention of cardiovascular disease is uncertain. In a randomized controlled trial, 305 older people were allocated vitamin D or placebo daily for 12 months. Primary outcomes were plasma concentrations of 25-hydroxy-vitamin D and secondary outcomes were blood pressure, and arterial stiffness in all participants at 6 and 12 months, plasma BNP levels in all participants at 12 months, and echocardiographic measures of cardiac function in a randomly selected subset (n=177) at 12 months. Mean (SE) plasma 25-hydroxy-vitamin D concentrations were 50 (SE 2) nmol/L at baseline and increased to 137 (2.4), 102 (2.4), and 53 (2.4) nmol/L in those allocated 4000 IU/d, 2000 IU/d of vitamin D, or placebo, respectively. Vitamin D had no significant effect on mean levels of blood pressure, or arterial stiffness, or on any echocardiographic measures of cardiac function, or plasma N-terminal prohormone of BNP levels at 12 months.

Publications linked to this award:

  1. Clarke R, Newman C, Tomson J, Hin H, Kurien R, Cox J, Lay M, Sayer J, Hill M, Emberson J, Armitage J. Estimation of the optimum dose of vitamin D for disease prevention in older people: rationale, design and baseline characteristics of the BEST-D trial. Maturitas. 2015;80:426-431.
  2. Hin H, Tomson J, Newman C, Kurien R, Lay M, Cox J, Sayer J, Hill M, Emberson J, Armitage J, Clarke R. Optimum dose of vitamin D for disease prevention in older people: BEST-D trial of vitamin D in primary care. Osteoporos Int. 2017;28(3):841-851.
  3. Tomson J, Hin H, Emberson J, Kurien R, Lay M, Cox J, Hill M, Arnold L, Leeson P, Armitage J, Clarke R. Effects of vitamin D on blood pressure, arterial stiffness, and cardiac function in older people after 1 year: BEST-D (Biochemical Efficacy and Safety Trial of Vitamin D). J Am Heart Assoc. 2017 Oct 24;6(10). pii: e005707. doi: 10.1161/JAHA.117.005707.
  4. Berlanga-Taylor, A., Plant, K., Dahl, A., Lau, E., Hill, M., Sims, D., Heger, A., Emberson, J., Armitage, J., Clarke, R. and Knight, J. (2018). Genomic Response to Vitamin D Supplementation in the Setting of a Randomized, Placebo-Controlled Trial. EBioMedicine, 31, pp.133-142.

  5. Beveridge, L., Khan, F., Struthers, A., Armitage, J., Barchetta, I., Bressendorff, I., Cavallo, M., Clarke, R., Dalan, R., Dreyer, G., Gepner, A., Forouhi, N., Harris, R., Hitman, G., Larsen, T., Khadgawat, R., Marckmann, P., Mose, F., Pilz, S., Scholze, A., Shargorodsky, M., Sokol, S., Stricker, H., Zoccali, C. and Witham, M. (2018). Effect of Vitamin D Supplementation on Markers of Vascular Function: A Systematic Review and Individual Participant MetaAnalysis. Journal of the American Heart Association, 7(11).
  6. Dr Joseph Tomson J. Doctor of Medicine Thesis (MD). “Vitamin D and cardiovascular disease” (University of Warwick, 2017).